Xoma reported $79.74M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US USD 251.43M 37.5M
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Ardelyx ARDX:US USD 119.88M 5.77M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Celldex Therapeutics CLDX:US USD 334.6M 33.38M
Chimerix CMRX:US USD 291.12M 240.35M
Curis CRIS:US USD 105.72M 7.68M
Eli Lilly And LLY:US USD 17.64B 524.7M
Emergent Biosolutions EBS:US USD 1.12B 34.3M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Life Technologies LIFE:US USD 84.63M 8.72M
Macrogenics MGNX:US USD 147.81M 19.82M
Novartis NOVN:VX USD 36.95B 1.19B
Novartis NVS:US USD 36.95B 1.19B
Prothena PRTA:US USD 524.56M 3.27M
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
Xoma XOMA:US USD 79.74M 7.52M
YTE INCY:US USD 3.82B 195.27M